Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Safer management of controlled drugs annual report

26th August 2010

The Care Quality Commission has published the 2009 annual report of the safer management of controlled drugs.


click here to view

Risk of photosensitivity reactions with topical keptoprofen

10th August 2010

Letters have been sent to healthcare professionals from the manufacturers of topical ketoprofen preparations (Oruvail gel, Sanofi-Aventis and Powergel, Menarini) summarising the results of the European Medicines Agency (EMA) review. The Committee for Medicinal Products for Human Use (CHMP) concluded that photosensitivity reactions of topical ketoprofen containing medicines are important undesirable effects but that the benefit/risk profile remains favourable. Several recommendations for safer use are listed including; not exposing treated areas to sunlight during treatment (even if cloudy) and for two weeks afterwards, not using topical ketoprofen under occlusive bandaging and washing hands thoroughly. These medicines should be available only under prescription. For more information see below.

click here to view

Update: octreotide monograph

3rd August 2010

The octreotide monograph has been fully updated and has been published in the Journal of Pain and Symptom Management as a therapeutic review (subscription required). This version supersedes the PCF3 (first print, 2007) and the website version (dated June, 2008).

Wilcock A and Twycross R (2010) Therapeutic Reviews: Octreotide. Journal of Pain and Symptom Management 40: 142—148.

click here to view